TUESDAY, SEPTEMBER 27TH 2011 407. Immunology and cell biology of asthma and COPD
John Blaikley,Julie Gibbs,Andrew Loudon,Stuart Farrow,Dave Singh,David Ray,Liu Xinyu,Shen Yongchun,Wen Fuqiang,Ying Binwu,Wang Tao,Xu Dan,Susanna Mandruzzato,Erica Bazzan,Graziella Turato,Kim Lokar-Oliani,Manuel Cosio,Catherine M. R. Thomas,Anna Miller-Larsson,Peter J. Barnes,Louise,E. Donnelly,Luiz F. Ferraz da Silva,Klaus F. Rabe,Annemarie M. van Schadewijk,Thais Mauad
2011-01-01
Abstract:printing supported by . Visit Chiesi at Stand D.30 TUESDAY, SEPTEMBER 27TH 2011 activity and obesity. Leptin is an adipokine with a not well-established functional role on airways function. The specific airway resistance (sRaw) and isolated bronchial rings reactivity were assessed on obese resistant (OR) and obese prone (OP) rats, fed with hight fat diet. Results were compared with data from Sprague Dawley (SD) rats fed with standard diet. In vitro experiments were performed on main left bronchus rings. Both contraction induced by 10μM acetylcholine (ACh) and terbutaline-induced relaxation were assessed. On OP bronchi, the terbutaline dose-response curve was shifted to the right and the maximal relaxant effect was decreased up to 20%. Leptin pretreatment did not significantly modify terbutaline relaxant effects on OR rats but restored terbutaline effects on OP bronchi. Inhibition of all NO synthases (NOS) with 10μM N(G)-nitro L-arginine methyl ester blocked the leptin effects. Aminoguanidine (inhibitor of inducible NOS) partially prevented the leptin effects. The ACh-induced sRaw variation was not significantly modify by intratracheal administration of leptin on OP, as compared with OR. On the other hand, the exogenous leptin significantly increased the sRaw on OR as compared with SD. These results suggest that leptin could have protective effects on airway hyperresponsiveness by stimulation of NO synthesis due to the activation mainly of constitutive NOS (cNOS), and not only the obesity but also the diet could modify the airways function. P3844 Immunocytochemical study of interleukin-1β in alveolar macrophages of patients with well-controlled and non-controlled asthma Svetlana Pospelova1, Vyacheslav Kravtsov2, Svetlana Sobchenko1, Alexander Parfionov2. 1Pulmonology, Medical Academy of Postgraduated Studies, St. Petersburg, Russian Federation; 2Laboratory of Cytology, Nikiforov Russian Centre for Emergency and Radiation Medicine, St. Petersburg, Russian Federation We have conducted dynamic immunocytochemical investigation of the level of Interleukin-1β (IL-1β) in alveolar macrophages of a group of patients (n=16) with well-controlled and non-controlled asthma. Induced sputum specimens from each of the patients were collected twice. Cytologic preparations of sputum were obtained via method of liquid cytology. Cytologic centriphugates were coloured on slides via immunocytochemical method with the use of monoclonal anti-IL-1β antibodies. The results of immunocytochemistry were evaluated using Histology Score method (HScore). The average value of the investigated index “content of IL-1β in alveolar macrophages” in patients with non-controlled asthma was 251,5±8,3 HScore, while in patients with well controlled asthma it came to 66,4±18,0 HScore. The level of IL-1β decreased more than five times in 14 of 16 patients as a result of their treatment which included education. Thus, the results of our study indicate that IL-1β is produced by alveolar macrophages in significant amount during non-controlled asthma and that its production decreases abruptly when asthma becomes well-controlled. P3845 Immune status in patients with bronchial asthma exacerbation and comorbide digestive system diseases Shamil Zagidullin, Elena Galimova, Guzel Nurtdinova, Rustem Zulkarneev. Internal Diseases (Propedeutics), Bashkortostan State Medical University, Ufa, Bashkortostan, Russian Federation Bronchial asthma (BA) is frequently linked with digestive system pathology Aim: To evaluate features of immune status in bronchial asthma (BA) patients with and without comorbide digestive system diseases (DSD). Materials and methods: Prospective, descriptive study of 90 hospitalized patients with bronchial asthma exacerbation and 31 healthy controls. Immune status was assessed via quantitation of lymphocytes subpopulations, immunoglobulins A,E,G,M, circulating immune complexes. Digestive system diseases were diagnosed via gastroscopy and ultrasonic scanning. Results: 61 (67,8%) patients with BA exacerbation suffered from digestive system diseases:gastritis, duodenitis-27 patients (30,0%), duodenum anabrosis-4 (4,5%), gastric-duodenum reflux-20 (22,2%), biliary dyskinesia-10 (11,1%). Immune response parameters were decreased in both groups of BA patients vs. controls. Patients with BA and DSD showed significant decrease of CD4, CD8 and IgA vs. controls and patients with BA without comorbidities. Immune status in patients with BA±DSD